Abstract |
In a randomized study comparing purified urinary FSH with recombinant FSH for IVF/intracytoplasmic sperm injection in patients with polycystic ovary syndrome, there was no significant difference between the mean total dose of FSH used, duration of stimulation, number of retrieved oocytes, number of mature oocytes, number of embryos transferred, or the ongoing pregnancy rate between the two groups. However, there were significantly more fertilized oocytes, a higher fertilization rate, more top-quality embryos, and more cryopreserved embryos in the urinary FSH group.
|
Authors | Mohamed Aboulghar, Waleed Saber, Yahia Amin, Mona Aboulghar, Ragaa Mansour, Gamal Serour |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 94
Issue 6
Pg. 2332-4
(Nov 2010)
ISSN: 1556-5653 [Electronic] United States |
PMID | 20188364
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Copyright | Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Recombinant Proteins
- Urofollitropin
- Follicle Stimulating Hormone
|
Topics |
- Adult
- Female
- Fertilization in Vitro
(methods)
- Follicle Stimulating Hormone
(adverse effects, therapeutic use)
- Humans
- Infertility, Female
(drug therapy, etiology)
- Ovarian Hyperstimulation Syndrome
(prevention & control)
- Ovulation Induction
(methods)
- Polycystic Ovary Syndrome
(complications, drug therapy)
- Pregnancy
- Pregnancy Rate
- Recombinant Proteins
(adverse effects, therapeutic use)
- Sperm Injections, Intracytoplasmic
(methods)
- Treatment Outcome
- Urofollitropin
(adverse effects, isolation & purification, therapeutic use)
- Young Adult
|